Amwell (AMWL) Misses Q3 EPS by 64c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Amwell® Announces Results for Third Quarter 2020
November 12, 2020 4:05 PM ESTTotal active providers of approximately 62,000 at the end of the third quarter increased 930% compared to a year ago Total visits of 1,414,000 in the third quarter increased 450% compared to a year ago Revenue of $62.6 million in the third quarter increased 80% compared to a year ago Announced new products: Amwell Now, Touchpoint Tablet software, and C500 telemedicine cart Provides initial 2020 guidance
BOSTON--(BUSINESS... More
